Cohort profile: understanding health service system needs for people with intellectual disability using linked data in New South Wales, Australia
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
This cohort profile describes one of the largest linked datasets in the world concerning the health of people with intellectual disability. The cohort comprises a retrospective group of 100,089 individuals with intellectual disability who received disability and/or health services in New South Wales, Australia. Of these participants, 34% were female, with a median age at cohort entry of 3 years (interquartile range, 0-19). A separate comparator cohort included 455,677 individuals, matched by 5-year age group, sex, and residential postcode at a 5:1 ratio. Initial results indicate that between 2001 and 2018, people with intellectual disability experienced more than double the rate of hospitalisations (538 vs. 235 per 1,000 person-years), as well as markedly higher rates of emergency department presentations (707 vs. 379 per 1,000 person-years) and use of ambulatory mental health services (1,012 vs. 157 per 1,000 person-years), relative to the comparator cohort. The largest disparities in hospital admissions were for mental disorders, dialysis, and diseases of the nervous system and sense organs. Furthermore, individuals with intellectual disability had more than double the rate of dispensed medications found in the comparator cohort. Of these medications, 46.6% were for the treatment of nervous system conditions, as opposed to 24.7% for the comparator cohort. The mean±standard deviation age at death was 52±19 years for people with intellectual disability and 64±22 years for the comparator participants.
Abstract
This cohort profile describes one of the largest linked datasets in the world concerning the health of people with intellectual disability. The cohort comprises a retrospective group of 100,089 individuals with intellectual disability who received disability and/or health services in New South Wales, Australia. Of these participants, 34% were female, with a median age at cohort entry of 3 years (interquartile range, 0-19). A separate comparator cohort included 455,677 individuals, matched by 5-year age group, sex, and residential postcode at a 5:1 ratio. Initial results indicate that between 2001 and 2018, people with intellectual disability experienced more than double the rate of hospitalisations (538 vs. 235 per 1,000 person-years), as well as markedly higher rates of emergency department presentations (707 vs. 379 per 1,000 person-years) and use of ambulatory mental health services (1,012 vs. 157 per 1,000 person-years), relative to the comparator cohort. The largest disparities in hospital admissions were for mental disorders, dialysis, and diseases of the nervous system and sense organs. Furthermore, individuals with intellectual disability had more than double the rate of dispensed medications found in the comparator cohort. Of these medications, 46.6% were for the treatment of nervous system conditions, as opposed to 24.7% for the comparator cohort. The mean±standard deviation age at death was 52±19 years for people with intellectual disability and 64±22 years for the comparator participants.
참고문헌 (36)
- American Psychiatric Association(APA), "Diagnostic and statistical manual of mental disorders", pp.33~ (2013), APA
- Maulik PK, "Prevalence of intellectual disability : a meta-analysis of population-based studies", Res Dev Disabil, 32, pp.419~436 (2011)[DOI]
- Cooper SA, "Multiple physical and mental health comorbidity in adults with intellectual disabilities : population-based cross-sectional analysis", BMC Fam Pract, 16, pp.110~ (2015)[DOI]
- Liao P, "Prevalence and incidence of physical health conditions in people with intellectual disability-a systematic review", PLoS One, 16, pp.e0256294~ (2021)[DOI]
- Tuffrey-Wijne I, "The barriers to and enablers of providing reasonably adjusted health services to people with intellectual disabilities in acute hospitals : evidence from a mixed-methods study", BMJ Open, 4, pp.e004606~ (2014)[DOI]
- Buckley N, "Prevalence estimates of mental health problems in children and adolescents with intellectual disability : a systematic review and meta-analysis", Aust N Z J Psychiatry, 54, pp.970~984 (2020)[DOI]
- Mazza MG, "Prevalence of co-occurring psychiatric disorders in adults and adolescents with intellectual disability : a systematic review and meta-analysis", J Appl Res Intellect Disabil, 33, pp.126~138 (2020)[DOI]
- Burke E, "Intellectual disabilities: health and social care across the lifespan" (2023), Springer
- Hirvikoski T, "Association of intellectual disability with all-cause and cause-specific mortality in Sweden", JAMA Netw Open, 4, pp.e2113014~ (2021)[DOI]
- Trollor J, "Cause of death and potentially avoidable deaths in Australian adults with intellectual disability using retrospective linked data", BMJ Open, 7, pp.e013489~ (2017)[DOI]
- Florio T, "Mortality among a cohort of persons with an intellectual disability in New South Wales, Australia", J Appl Res Intellect Disabil, 28, pp.383~393 (2015)
- Glover G, "Mortality in people with intellectual disabilities in England", J Intellect Disabil Res, 61, pp.62~74 (2017)[DOI]
- Ouellette-Kuntz H, "Understanding information about mortality among people with intellectual and developmental disabilities in Canada", J Appl Res Intellect Disabil, 28, pp.423~435 (2015)[DOI]
- Tyrer F, "Mortality, predictors and causes among people with intellectual disabilities : a systematic narrative review supplemented by machine learning", J Intellect Dev Disabil, 46, pp.102~114 (2020)[DOI]
- Mann C, "A scoping review of clusters of multiple long-term conditions in people with intellectual disabilities and factors impacting on outcomes for this patient group", J Intellect Disabil, 27, pp.1045~1061 (2023)[DOI]
- Lonchampt S, "Prevalence of polypharmacy and inappropriate medication in adults with intellectual disabilities in a hospital setting in Switzerland", Front Psychiatry, 12, pp.614825~ (2021)[DOI]
- Haider SI, "Prevalence and factors associated with polypharmacy in Victorian adults with intellectual disability", Res Dev Disabil, 35, pp.3071~3080 (2014)[DOI]
- O’Dwyer M, "Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population : a cross-sectional observational nationwide study", BMJ Open, 6, pp.e010505~ (2016)[DOI]
- Lunsky Y, "Antipsychotic medication prescription patterns in adults with developmental disabilities who have experienced psychiatric crisis", Res Dev Disabil, 33, pp.32~38 (2012)[DOI]
- Sheehan R, "Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability : UK population based cohort study", BMJ, 351, pp.h4326~ (2015)[DOI]
- Tyrer P, "Drug treatments in people with intellectual disability and challenging behaviour", BMJ, 349, pp.g4323~ (2014)[DOI]
- Odalović M, "Psychotropic medicines’ prevalence, patterns and effects on cognitive and physical function in older adults with intellectual disability in Ireland : longitudinal cohort study, 2009-2020", BJPsych Open, 10, pp.e39~ (2024)[DOI]
- Saari K, "Hyperlipidemia in persons using antipsychotic medication : a general population-based birth cohort study", J Clin Psychiatry, 65, pp.547~550 (2004)[DOI]
- Lennox NG, "Audit and comprehensive health assessment programme in the primary healthcare of adults with intellectual disability : a pilot study", J Intellect Disabil Res, 45, pp.226~232 (2001)[DOI]
- Weise J, "Primary health care for people with an intellectual disability : an exploration of consultations, problems identified, and their management in Australia", J Intellect Disabil Res, 61, pp.399~410 (2017)[DOI]
- Cocks E, "Health status and use of medications by adults with intellectual disability in Western Australia", J Intellect Dev Disabil, 41, pp.87~96 (2016)[DOI]
- Haveman M, "Ageing and health status in adults with intellectual disabilities : results of the European POMONA II study", J Intellect Dev Disabil, 36, pp.49~60 (2011)[DOI]
- Hermans H, "Multimorbidity in older adults with intellectual disabilities", Res Dev Disabil, 35, pp.776~783 (2014)[DOI]
- Reppermund S, "Health and wellbeing of people with intellectual disability in New South Wales, Australia : a data linkage cohort", BMJ Open, 9, pp.e031624~ (2019)[DOI]
- Reppermund S, "Cohort profile : a data linkage cohort to examine health service profiles of people with intellectual disability in New South Wales, Australia", BMJ Open, 7, pp.e015627~ (2017)[DOI]
- "Data linkage protocols using a statistical linkage key" (2005)[URL]
- Karmel R, "Empirical aspects of record linkage across multiple data sets using statistical linkage keys : the experience of the PIAC cohort study", BMC Health Serv Res, 10, pp.41~ (2010)[DOI]
- "Supplementary codes for chronic conditions: evaluation report for population health monitoring" (2023)[URL]
- "2033.0.55.001 - Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2016" (2018)[URL]
- "1270.0.55.001 - Australian Statistical Geography Standard (ASGS): volume 1 - main structure and greater capital city statistical areas, July 2016" (2016)[URL]
- Mellish L, "The Australian Pharmaceutical Benefits Scheme data collection : a practical guide for researchers", BMC Res Notes, 8, pp.634~ (2015)[DOI]